title: Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.
abstract: In vitro liver models provide essential information for evaluating drug metabolism, metabolite formation, and hepatotoxicity. Interfacing liver models with other organ models could provide insights into the desirable as well as unintended systemic side effects of therapeutic agents and their metabolites. Such information is invaluable for drug screening processes particularly in the context of secondary organ toxicity. While interfacing of liver models with other organ models has been achieved, platforms that effectively provide human-relevant precise information are needed. In this concise review, we discuss the current state-of-the-art of liver-based multiorgan cell culture platforms primarily from a drug and metabolite perspective, and highlight the importance of media-to-cell ratio in interfacing liver models with other organ models. In addition, we briefly discuss issues related to development of optimal liver models that include recent advances in hepatic cell lines, stem cells, and challenges associated with primary hepatocyte-based liver models. Liver-based multiorgan models that achieve physiologically relevant coupling of different organ models can have a broad impact in evaluating drug efficacy and toxicity, as well as mechanistic investigation of human-relevant disease conditions.
authors.affiliation: 1 Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School and Shriners Hospital for Children , Boston, Massachusetts.
authors.forename: Shyam Sundhar
authors.initials: SS
authors.lastname: Bale
authors.affiliation: 1 Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School and Shriners Hospital for Children , Boston, Massachusetts.
authors.forename: Laura
authors.initials: L
authors.lastname: Moore
authors.affiliation: 1 Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School and Shriners Hospital for Children , Boston, Massachusetts.|2 Department of Biomedical Engineering, Rutgers University , Piscataway, New Jersey.
authors.forename: Martin
authors.initials: M
authors.lastname: Yarmush
authors.affiliation: 1 Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School and Shriners Hospital for Children , Boston, Massachusetts.
authors.forename: Rohit
authors.initials: R
authors.lastname: Jindal
mesh_terms: D004353:Drug Evaluation, Preclinical; D064420:Drug-Related Side Effects and Adverse Reactions; D022781:Hepatocytes; D006801:Humans; D008099:Liver